A. Argon Et Al. , "Safety of paclitaxel in a patient with ovarian cancer and hyperbilirubinemia due to Rotor's syndrome.," Gynecologic oncology , vol.85, no.2, pp.362-4, 2002
Argon, A. Et Al. 2002. Safety of paclitaxel in a patient with ovarian cancer and hyperbilirubinemia due to Rotor's syndrome.. Gynecologic oncology , vol.85, no.2 , 362-4.
Argon, A., Aydiner, A., Tas, F., Saip, P., & Topuz, E., (2002). Safety of paclitaxel in a patient with ovarian cancer and hyperbilirubinemia due to Rotor's syndrome.. Gynecologic oncology , vol.85, no.2, 362-4.
Argon, A Et Al. "Safety of paclitaxel in a patient with ovarian cancer and hyperbilirubinemia due to Rotor's syndrome.," Gynecologic oncology , vol.85, no.2, 362-4, 2002
Argon, A Et Al. "Safety of paclitaxel in a patient with ovarian cancer and hyperbilirubinemia due to Rotor's syndrome.." Gynecologic oncology , vol.85, no.2, pp.362-4, 2002
Argon, A. Et Al. (2002) . "Safety of paclitaxel in a patient with ovarian cancer and hyperbilirubinemia due to Rotor's syndrome.." Gynecologic oncology , vol.85, no.2, pp.362-4.
@article{article, author={A Argon Et Al. }, title={Safety of paclitaxel in a patient with ovarian cancer and hyperbilirubinemia due to Rotor's syndrome.}, journal={Gynecologic oncology}, year=2002, pages={362-4} }